| 查看: 5385 | 回复: 10 | |||
[交流]
cancer research 投稿要求
|
|||
| 想请教一下，cancer research的投稿有什么要求吗？文章格式有什么要求吗？ |
回复此楼» 猜你喜欢
2026年博士申请求捞
已经有3人回复
-
2026博士或科研助理转27年博士
已经有6人回复
-
26年博士申请自荐-电催化
已经有6人回复
-
国自科送审了吗
已经有11人回复
-
博士招生
已经有5人回复
-
夜，静悄悄的
已经有8人回复
-
研究生做的很差，你们会让毕业吗？
已经有6人回复
-
26年申博自荐-计算机视觉
已经有4人回复
» 本主题相关价值贴推荐，对您同样有帮助:
- sci期刊最新变化！
已经有30人回复
- 投过Journal of Nanoparticle Research帮忙：此期刊对形成机理的解释有要求吗
已经有3人回复
- British Journal of Cancer投稿
已经有9人回复
- African Journal of Microbiology Research老是要求我审稿，怎么办
已经有4人回复
- 求助生物、医学类1分左右的SCI投稿期刊选择（论文内容为癌症细胞的生物学研究）
已经有5人回复
- Research Highlights的格式需要怎么写才符合杂志要求
已经有9人回复
- 投稿Nano Research & J. Mater. Chem. ?
已经有19人回复
- 想投European Journal of Medicinal Chemistry，投稿要求怎么找啊？
已经有3人回复
- 【转载】A Postdoctoral Position in Hematological Cancer Research
已经有1人回复
- 关于 SCI 中 常见缩写的规则
已经有18人回复
» 抢金币啦！回帖就可以得到:
-
坐标南京，诚租女友
+5/9321
-
昆明理工大学交通载运车辆方向招收2026年秋季入学博士生2名
+3/174
-
工科男，工作稳定，希望能遇到有趣的她
+1/169
-
国自然申报交流祈福
+4/126
-
坐标广州，征女友
+2/124
-
东北林业大学化学专业招申请考核博士生
+1/95
-
湖南师范大学化学化工学院李斌课题组招收2026级博士生
+1/83
-
求认识靠谱妹纸@山西
+1/71
-
山东征女友，坐标济南
+1/70
-
松山湖材料实验室-大连理工大学联合招收2027年博士研究生调剂考生若干名
+1/34
-
双一流高校-南京林业大学-化学工程学院-国家海外优青团队招2026级博士（5月15号截止）
+1/31
-
坐标南京
+1/20
-
大连理工大学张硕课题组2026年秋季博士生额外招生（补招1人，有机合成/糖化学方向）
+1/14
-
类器官/器官芯片 有编制研究员
+1/11
-
英国大学招收电子散热及数字孪生研究方向的博士生
+1/8
-
【硕士生补录】澳科大诚招2026年秋季药剂学硕士研究生1-2名
+1/5
-
复旦大学2026年“申请-考核”制博士招生
+1/5
-
招收2026年秋季入学博士生1名（河北工业大学/北京科技大学联合 增材制造/生物材料）
+1/3
-
中南大学地信院潘老师团队招收航天摄影测量与三维计算机视觉方向2026年入学博士生
+1/3
-
【急招】北京航空航天大学 | 超声脑机接口方向 | 2026年博士研究生
+1/3
★ ★ ★
小木虫: 金币+0.5, 给个红包，谢谢回帖
看天: 金币+2, 鼓励一下 2012-11-20 21:10:49
小木虫: 金币+0.5, 给个红包，谢谢回帖
看天: 金币+2, 鼓励一下 2012-11-20 21:10:49
2楼2012-11-16 17:39:30
3楼2012-11-16 20:37:01
4楼2012-11-19 04:22:18
5楼2012-11-20 13:40:02
6楼2012-11-20 18:49:42
7楼2012-11-21 10:46:04
8楼2014-02-03 23:51:23
9楼2014-02-03 23:52:08
★
小木虫: 金币+0.5, 给个红包，谢谢回帖
小木虫: 金币+0.5, 给个红包，谢谢回帖
|
Cancer Research (CanRes): Instructions for Authors SmartSubmit Scope Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention, and epidemiologic research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology. Please note that the journal is unable to entertain pre-submission inquiries. See the Submission Procedures section of the Instructions for Authors for information on submitting a manuscript for consideration. Papers are stringently reviewed, and only those that report results of novel, timely, and broadly-significant research meeting high standards of scientific merit are accepted for publication. The following criteria provide an overview of the types of studies considered by the journal: Findings which have not been previously published in another tumor model. Studies performed in multiple cell lines. Conclusions which are not representative of incremental findings. Studies which include a clearly written title and abstract which communicate the study's impact of significance to non-experts. An incisive rationale that could interest a broad audience. Manuscripts containing in vivo data. Although in vivo data is not required, studies containing this data are preferred. A potentially generalizable, broad impact conclusion. Studies which describe RNA interference (RNAi) must contain one non-specific control and two specific siRNAs for each knockdown target of interest. Additional data showing that knockdown at the level of protein expression (not just mRNA) was achieved is required. Categories of Publication Top The following types of articles will be considered for publication. Note that word counts are exclusive of references. Authors are advised that submissions not adhering to the guidelines provided below, including word counts, may be returned unreviewed. Research Articles Original studies offering broad impact across the fields of basic, preclinical, clinical, prevention and epidemiologic cancer research. The reports should be well-documented, novel, and significant to the field as a whole. The Editor-in-Chief and members of the senior editorial board reserve the right to edit title, abstract, and précis for articles that are accepted to improve their clarity, brevity, and quality. 250-word abstract 5,000 words of text 7 tables and/or figures (Please keep the number of panels per figure to an absolute minimum) 50 references Priority Reports Short, definitive reports of findings of high impact, significance, and timeliness. These reports receive an accelerated review. Papers submitted as Priority Reports should include a section for Materials and Methods as well as Results and Discussion (Results and Discussion may be combined but Materials and Methods may not be combined with any other section). The Editor-in-Chief and members of the senior editorial board reserve the right to edit title, abstract, and précis for articles that are accepted, to improve their clarity, brevity, and quality. 250-word abstract 2,500 words of text 4 tables and/or figures — Please note that each figure or table is limited to a maximum of 4 panels. 20 references Reviews Articles that review a timely subject important to cancer researchers. Reviews must be written as concisely as possible. Authors of unsolicited Review Articles must first submit an outline of the proposed article for consideration. The outline should be sent to the attention of Dr. Danny R. Welch, Deputy Editor for Reviews (Fax: (215) 440-9354; E-mail: cancerres@aacr.org). All Review Articles, whether invited or not, will be subject to peer review. The length restrictions for this category of publication are provided below. Longer reviews will be considered only at the discretion of the Deputy Editor for Reviews. 200-word abstract 2,000 words of text 1 original figure with a maximum of 4 panels 30 references Perspectives in Cancer Research Articles that present fresh insights on a very active or underdeveloped area of research, with a personal viewpoint on the area, its pressing issues, or its development. 200-word abstract 3,000 words of text 3 tables and/or figures, each with a maximum of 4 panels 30 references Public Issues Brief articles on topics of interest to cancer researchers and the general public. These topics might include articles on advocacy for funding cancer research, government relations, training in the field, public education, or science education. 2,000 words of text Letters to the Editor In the spirit of open scientific dialogue, the Editors invite the submission of correspondence that presents considered opinions in response to articles published in the journal. Letters to the Editor will be peer reviewed and, if found to meet the requisite publication criteria (scholarly commentary on a subject of importance and interest to the broad readership), the Letter may be sent to the author(s) of the originally published article and possibly to other interested parties for a response to be published in the same issue of the journal as the Letter. Please note that the journal will not consider Letters to the Editor regarding Cancer Research articles that were published more than 3 months prior. Correspondence concerning articles that have not been published in Cancer Research will not be considered. The length restrictions for this category of publication are as follows: 400 words of text 5 references, the first of which must be the citation for the original article under discussion Letters may contain figures or tables only if they show data that refute the conclusions of the originating article. Figures or tables showing unpublished data in support of the conclusions of the originating article will not be considered. Include a title: "Running title of the original article" — Letter Meeting Reports Brief reports of symposia and conferences in cancer research. Reports must be submitted within 2 months of the meeting date in order to maintain their timeliness. Only those Meeting Reports dealing with topics of interest to the readership that contain novel information and insights from the meeting will be accepted for publication. A Meeting Report should offer a thoughtful, critical commentary that shows an appreciation of the connections among various presentations and reveals the consensus, if any, that emerged on matters of importance at the meeting. Before submitting a Meeting Report for consideration, potential authors must send a letter to the attention of Dr. Mariano Barbacid, Deputy Editor for Meeting Reports, to inquire whether the suggested meeting satisfies criteria for consideration. Letters of inquiry should be sent to the Publications Office (Fax: (215) 440-9354; E-mail: cancerres@aacr.org). Length restrictions for this category of publication are as follows: 100 word abstract 2,500 words of text Figures and/or tables are not permitted without prior approval from the Editors References, if necessary, must be kept to a minimum A statement of the purpose of the meeting, an integrated summary of the findings presented, and recommendations for future research The names and affiliations of key speakers should be given in an appendix that is submitted as supplemental information, not as part of the manuscript text Mathematical Oncology Research Articles Published in the Integrated Systems and Technologies section of the journal, Mathematical Oncology articles include mathematical approaches to problems in cancer research. These articles will contain new testable hypotheses, integration of theory and experimental data, facilitation of wide-ranging investigations, and basic laws of biology. The format and length restrictions for this category of publication are as follows: Title: 150 characters (not including spaces) Abstract: 350 words, in the following construction: Summarize the background, cancer significance, and question "set the stage"  Describe the findings ("deliver the result" Summarize the meaning and implication of the advance ("place in context" Succinct nonmathematical description of the major results; please use the subheading Major Findings to differentiate this portion of the abstract Quick Guide to Equations and Assumptions: Up to 5 equations, 800 words maximum Present key equations; for each, include a description and/or definition of the components of the equation Present all major assumptions of the model Body Text: 5,000 text words Figures and/or Tables: maximum of 7. Authors are asked to keep the number of panels per figure to an absolute minimum. Acceptable formats: TIFF, EPS, PPT Submit figures and tables as separate files References: 50 Supplementary Material: Submit the details of the computational procedures and a flowchart of the algorithm(s) as Supplementary Material. Cancer Research encourages that all programs used in the calculations or detailed instructions to replicate the major findings also be provided as Supplementary Material. Prior to depositing a program, you must ensure and attest that the posted version executes properly. Deposit data used for analysis (curve fitting, approximations, parameter estimation, etc.) as Supplementary Material. |
10楼2014-02-04 03:03:16
11楼2014-08-12 17:11:11